Literature DB >> 20924318

Biomarkers of neutrophil-mediated glutathione and protein oxidation in tracheal aspirates from preterm infants: association with bacterial infection.

D Tim Harwood1, Brian A Darlow, Fook-Choe Cheah, Nicolette McNeill, Patricia Graham, Christine C Winterbourn.   

Abstract

Bronchopulmonary dysplasia is associated with neutrophil infiltration into the lungs and oxidative injury. However, the pathological importance of neutrophil oxidants is still not clear. Nosocomial pneumonia is also implicated, but the evidence is limited, in part because of the difficulty of distinguishing genuine infection from bacterial colonization. Good biomarkers of neutrophil oxidant activity and lung infection are needed. We tested whether glutathione sulfonamide, a product of glutathione oxidation by myeloperoxidase-derived hypochlorous acid (HOCl) and a potential new neutrophil oxidant biomarker, is detectable in endotracheal aspirates from ventilated preterm infants. As infectious organisms stimulate neutrophils to generate HOCl, we determined whether levels of HOCl-specific biomarkers were increased in samples that were bacterial culture positive. Glutathione sulfonamide was detected in 66 of 87 endotracheal aspirate samples. Levels correlated with myeloperoxidase activity and another HOCl-specific marker, chlorotyrosine. Median levels of glutathione sulfonamide (4-fold) and other biomarkers (2-fold) were significantly higher in culture positive aspirates. Staphylococcus epidermidis, a frequent colonizer, was associated with glutathione sulfonamide levels no different from those in negative samples. Glutathione sulfonamide showed good sensitivity and specificity for detecting bacterial growth and has promise for detecting lung infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20924318     DOI: 10.1203/PDR.0b013e3181ff2378

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  The Relationship Between Airway Antioxidant Levels, Alcohol Use Disorders, and Cigarette Smoking.

Authors:  Ellen L Burnham; Alicia McNally; Jeanette Gaydos; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2016-09-14       Impact factor: 3.455

2.  Exhaled breath condensate in intubated neonates--a window into the lung's glutathione status.

Authors:  Maria I Rosso; Susan Roark; Esther Taylor; XiaoDu Ping; Janine M Ward; Katherine Roche; Courtney McCracken; Lou Ann S Brown; Theresa W Gauthier
Journal:  Respir Res       Date:  2014-01-07

Review 3.  Oxygen and oxidative stress in the perinatal period.

Authors:  Isabel Torres-Cuevas; Anna Parra-Llorca; Angel Sánchez-Illana; Antonio Nuñez-Ramiro; Julia Kuligowski; Consuelo Cháfer-Pericás; María Cernada; Justo Escobar; Máximo Vento
Journal:  Redox Biol       Date:  2017-03-12       Impact factor: 11.799

Review 4.  The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.

Authors:  Nathaniel Teng; Ghassan J Maghzal; Jihan Talib; Imran Rashid; Antony K Lau; Roland Stocker
Journal:  Redox Rep       Date:  2016-11-25       Impact factor: 4.412

5.  Early molecular markers of ventilator-associated pneumonia in bronchoalveolar lavage in preterm infants.

Authors:  Alejandro Pinilla-Gonzalez; Inmaculada Lara-Cantón; Laura Torrejón-Rodríguez; Anna Parra-Llorca; Marta Aguar; Julia Kuligowski; José David Piñeiro-Ramos; Ángel Sánchez-Illana; Ana Gimeno Navarro; Máximo Vento; María Cernada
Journal:  Pediatr Res       Date:  2022-09-07       Impact factor: 3.953

6.  Changes in oxidative stress from tracheal aspirates sampled during chest physical therapy in hospitalized intubated infant patients with pneumonia and secretion retention.

Authors:  Jirakrit Leelarungrayub; Thirasak Borisuthibandit; Araya Yankai; Kritsana Boontha
Journal:  Ther Clin Risk Manag       Date:  2016-09-06       Impact factor: 2.423

7.  Antioxidant Capacity of Preterm Neonates Assessed by Hydrogen Donor Value.

Authors:  Melinda Matyas; Monica G Hasmasanu; Gabriela Zaharie
Journal:  Medicina (Kaunas)       Date:  2019-10-30       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.